ARCHIVES

NCI Chips In $2 Million For AACR Meeting; Advisors, Senior Staff Not Consulted.

This article is from The Cancer Letter archive.

Vol. 29 No. | August 12, 2003

Download PDF Visit The Full Archive

Related Articles

Phase II Elotuzumab Study Demonstrates 33 Months PFS

July 26, 2013

In Brief: Sullivan Will Be Secretary Most Knowledgeable About Cancer Program; Ihde Names ‘JNCI’ Editor

January 6, 1989

Access to mammography needs improvement, IOM National Cancer Policy Board report finds.

June 11, 2004

Consolidation Unlikely to Save Money

December 17, 2010

NCI Cooperative Groups Begin Trial Of Individualized Rx For Breast Cancer

May 26, 2006

Gallo, Collaborators Map Entire Genetic Structure Of HTLV-III

January 25, 1985